Vemurafenib as first-line therapy in BRAF -V600E-mutant Erdheim-Chester disease with CNS involvement

  1. Fernández-Eulate, G.
  2. Muñoz-Lopetegi, A.
  3. Ruiz, I.
  4. Urtasun, M.
Journal:
BMJ Case Reports

ISSN: 1757-790X

Year of publication: 2019

Volume: 12

Issue: 11

Type: Article

DOI: 10.1136/BCR-2018-228280 GOOGLE SCHOLAR

Sustainable development goals

Data source: Scopus